To validate the differential expression of SUCLG2 in PCa, we conducted qPCR analysis to compare the mRNA expression of SUCLG2 in 10 pairs of tumor tissues and adjacent normal tissues. This evidence concerns the gene SUCLG2 and posterior cortical atrophy.